2003
DOI: 10.1002/lsm.10188
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD‐S31

Abstract: The present study demonstrates that PAD-S31 may serve as a potent photosensitizer for PDT. Furthermore, it is expected that this therapy will be clinically useful for the treatment of patients with oral carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 25 publications
0
15
0
Order By: Relevance
“…age‐related macular degeneration) (Huang, ). Photodynamic therapy involves the use of photosensitizers (PS), which accumulate in tumours and are subsequently activated by visible light of wavelength matched to their absorption spectra (Date et al ., ). Low systemic toxicity and the ability to selectively destroy tumours accessible to light are the advantages of PDT over the other conventional cancer therapies.…”
Section: Introductionmentioning
confidence: 97%
“…age‐related macular degeneration) (Huang, ). Photodynamic therapy involves the use of photosensitizers (PS), which accumulate in tumours and are subsequently activated by visible light of wavelength matched to their absorption spectra (Date et al ., ). Low systemic toxicity and the ability to selectively destroy tumours accessible to light are the advantages of PDT over the other conventional cancer therapies.…”
Section: Introductionmentioning
confidence: 97%
“…Photodynamic therapy (PDT) is a promising cancer treatment in which a photosensitizing drug accumulates in tumors and is subsequently activated by visible light of an appropriate wavelength matched to the absorption (Date et al , 2003). The advantages of this method, as compared to other conventional cancer treatment modalities, are its low systemic toxicity and its ability to destroy tumors selectively (Gaullier et al , 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, deep and large tumors may not be able to be treated using this method. It has been recognized that the method is only efficient on tumors with a depth of ≤1.0 cm (11,12). …”
Section: Discussionmentioning
confidence: 99%